BridgeMD
New treatment option for Bariatric Surgery Candidate
Official title The Poor Responders Study
ClinicalTrials.gov ID: NCT05404061
What this study is testing
- What it's testing
- Obesity and type 2 diabetes are major causes of illness and premature death worldwide and their incidence is increasing rapidly. Bariatric surgery is considered as the "gold-standard" surgical treatment for both conditions.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 70
You may be able to join if
- Aged 18 -70 years.
- Male or female.
- Previous bariatric surgery for obesity and/or diabetes (studies 1 and 2).
- ≥1 year interval after bariatric surgery (studies 1 and 2).
- Awaiting bariatric surgery at the Imperial Weight Centre (study 3)
You likely can't join if
- History of any medical, psychological or other condition, or use of any medications, including over-the-counter products, which, in the opinion of...
- Without access at home to a telephone or other factor likely to interfere with ability to participate reliably in the study.
- Pregnancy or breastfeeding.
- Unable to maintain adequate contraception for the duration of the study and for one month afterwards.
- History of hypersensitivity to any of the components of the subcutaneous infusions.
- Donated blood during the preceding 3 months or intention to do so before the end of the study.
See the full eligibility criteria
- Aged 18 -70 years.
- Male or female.
- Previous bariatric surgery for obesity and/or diabetes (studies 1 and 2).
- ≥1 year interval after bariatric surgery (studies 1 and 2).
- Awaiting bariatric surgery at the Imperial Weight Centre (study 3)
- Able to give informed consent.
- History of any medical, psychological or other condition, or use of any medications, including over-the-counter products, which, in the opinion of the investigators, would either interfere with the study or potentially...
- Without access at home to a telephone or other factor likely to interfere with ability to participate reliably in the study.
- Pregnancy or breastfeeding.
- Unable to maintain adequate contraception for the duration of the study and for one month afterwards.
- History of hypersensitivity to any of the components of the subcutaneous infusions.
- Donated blood during the preceding 3 months or intention to do so before the end of the study.
- Any other co-morbidity that would compromise the validity of the study or the safety of the participant such as heart failure or clinically apparent cardiovascular disease.
- Anatomical or endocrinological pathology causing poor weight loss or weight regain
- Uncontrolled hypertension (systolic blood pressure of 160 mmHg or above and/or diastolic blood pressure of 100 mmHg or above)
- Participation in a research study within the last two months.
- Unable to speak English (this is relevant to answering the psychological questionnaires)
The study team makes the final eligibility decision.
Where it's taking place
- London, United Kingdom
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 70 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include London, United Kingdom. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.